At 3H Medi Solutions, we have conducted exhaustive studies about the scope of hypertension in Japan and its various treatment procedures. According to the Japanese society of Hypertension, around 43 million people in Japan are hypertensive and only 50 percent of them undergo any sort of medical treatment. As a result, Hypertension is one of […]

In India, 3H Medi Solutions incorporates the use of unique and highly efficient methods for patient recruitment. These advanced techniques of patient recruitment are based on well thought out and diligently crafted strategies like Site specific Database Management to identify Volunteer Patients, strategically planned recruitments based on protocol requirements and site selection with the help […]

A silent and key player in the sustenance of patient participation for clinical trial and the resultant patient satisfaction is the alignment of mission and values of the clinical trial with the patient goal. In order to understand this, before deciding to participate in the trial it is extremely advantageous for the patient to arrive […]

AstraZeneca K.K. (“AstraZeneca,” Head Office: Kita-ku Osaka-shi, President: Stefan WoxströmA) and CROèe Inc. (“CROèe,” Head Office: Toshima-ku Tokyo, President: Sho Ando) surveyed patients with advanced or recurrent non-small cell lung cancer on their attitudes toward medication. With an increasing number of options, treatment of advanced and recurrent non-small cell lung cancer is becoming more complicated. […]

As a result of having the largest population, China is a country with the highest number of potential patients. Unfortunately, China’s patient pool remains largely untapped due to several country-specific challenges and obstacles. One of the major issues is the lack of widespread awareness within the general Chinese population regarding the clinical trials. Even the […]

As a Patient recruitment specialised Tokyo based PRO-cum-CRO, CROee got an access to a massive database of over 20 million registered patients from more than 400 sites in Japan other than its own 810,000 registered patient under CROee Database. The database includes details of patient’s medical history, hospitalisation-history, symptoms of the disease, participated clinical trials […]

 In Japan, the Pharmaceutical and Medical Device Agency (PMDA) is responsible from the beginning of preliminary non-clinical phases through the late phases including the pivotal clinical trials.  interestingly, increasing fiscal burden and ageing society and decreasing population posing the challenges as well as emergence of unseen opportunities in Japanese pharmaceutical market. Japanese pharma economy is […]

 A great necessity of stronger alliance withlocal partner phoenixed APRO into AsianNetwork.  CROee’s Asian Network withmore country (Japan, China, Korea,Taiwan and Malaysia) to support in Asia. After aligning together withtrusted and experienced local partners enable us to support the Global Studywith more ease and professionalism. Our local partner better equipped with all required services and […]

1. Introduction Patient centricity is a term that is often used to mean ‘focusing on the patient’. In recent years, ‘patient centricity activities’ have come to be proactively implemented as a part of trends aiming to develop medicinal products that are more focused on patients at pharmaceutical manufacturers in Europe and America. These patient centricity […]

CROee supported Phase Ⅲ global clinical study for chronic lower back pain and osteoarthritis, achieving the target number of cases in Japan. CROee, Inc (Headquarters: Toshima-ku, Tokyo President: Sho Ando) contributed to the achievement of enrollment goals for a phase 3 global study sponsored by Pfizer Inc. (Headquarters: Tokyo, President: Akihisa Harada) by providing patients […]